Global E-cigarette Market Weekly (1.15-1.21)

Industry Insight by 2FIRSTS
Jan.22.2024
Global E-cigarette Market Weekly (1.15-1.21)
In a challenging market, big cigarette brands are entering Japan, while Malaysia pushes for e-liquid regulation. Can Korea's e-cigarette market rise in 2024?

The "credit society" with airtight regulations, stringent production conditions, and advertisers who constantly switch channels make it challenging for new tobacco brands to enter the Japanese market. However, as small brands face entry barriers and believe in the vast market potential after the relaxation of zero nicotine restrictions, established brands have started to seize this opportunity and expand their distribution.

 

The Malaysian E-Cigarette Consumers Association has announced that they have shared the findings of the 2FIRSTS report with local consumers and will continue to advocate for local e-liquid regulations.

 

In 2023, multiple well-known disposable e-cigarette brands such as ELFBAR and VUSE have entered the South Korean market. Simultaneously, South Korean conglomerates are also actively establishing their presence in the e-cigarette industry. This series of developments has the potential to disrupt the existing landscape of the South Korean e-cigarette market. In light of these changes, the question arises: Can the South Korean e-cigarette market thrive in 2024?

 

On January 18th, a backbench debate took place in the British Parliament, allowing backbench MPs to raise local or national issues and receive responses from relevant government ministers. The debate focused on the regulation of e-cigarettes in the UK, the World Health Organization (WHO), and the contrasting views between the organization and the British government regarding e-cigarettes.

 

On January 18, 2024, 2FIRSTS and CNR News held a signing ceremony for the ESG projects in the vaping industry, accompanied by the release of the "2023 Global Vaping Industry ESG Development Report" at the CNR News headquarters in Beijing. The event was attended by Wu Gang, Deputy Editor-in-Chief of CNR News, Zhao Tong, Co-founder and CEO of 2FIRSTS, Hu Lishan, Senior Director of the Financial and Economic Department at CNR News, and Hou Yuhuan, Global Vice President and Executive Editor-in-Chief of 2FIRSTS.

 

Blu's former factory, Tianchang Group, experiences a 79% decrease in e-cigarette sales and plans to seek new customers to expand its customer base.

 

The U.S. Food and Drug Administration (FDA) has issued a Marketing Denial Order (MDO) to SMOK, a manufacturer of 22 e-cigarette products. Please refer to the detailed list at the end of the article.

 

Guangdong Liwang New Energy Co., Ltd. received three institutional visits and highlighted its advantages and future plans in the lithium-ion battery business.

 

Vuse Go 800 is set to be widely available in South Korea, with distribution expanding to include 30,000 convenience stores and tobacco shops throughout the country.

 

SKE, a company specializing in electronic atomizer components, has announced its plan to establish an industrial park in Guangshui City, Hubei Province, with a total investment of 1 billion RMB.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Japan Tobacco International Malaysia Appoints Didier Ellena as Managing Director; Predecessor Reassigned to North Asia Role
Japan Tobacco International Malaysia Appoints Didier Ellena as Managing Director; Predecessor Reassigned to North Asia Role
Japan Tobacco International (JTI) Malaysia has appointed Didier Ellena as managing director, effective Jan 5. Ellena has spent more than 30 years with JTI and has held leadership roles across multiple countries and regions. His predecessor, Juliana Mohd Yahaya, will become vice president of sales and marketing for JTI North Asia.
Jan.15 by 2FIRSTS.ai
Myanmar announces ban on e-cigarettes, covering imports/exports, sales, possession and use
Myanmar announces ban on e-cigarettes, covering imports/exports, sales, possession and use
Myanmar’s Ministry of Health said it has received cabinet authorization to enforce an e-cigarette ban under the Essential Supplies and Services Law, listing prohibited acts including the import, export, sale, possession, storage, carrying, distribution and use of vaping products.
Feb.26 by 2FIRSTS.ai
Special Report|Russia scales back anti-vaping drive, limits ban to single-region trial
Special Report|Russia scales back anti-vaping drive, limits ban to single-region trial
After months of debate, Russian lawmakers have retreated from plans for a nationwide vaping ban, opting instead for a single-region pilot. The shift reflects pressure from business groups and fiscal authorities, amid warnings that sweeping prohibitions could fuel illegal trade while undermining efforts to regulate the market.
Jan.22
Isle of Wight councillors raise concerns about youth vaping; one says it may be seen “akin to asbestos”
Isle of Wight councillors raise concerns about youth vaping; one says it may be seen “akin to asbestos”
Concerns about the effects of vaping on young people and public health were raised at County Hall, the report said, with Cllr Chris Jarman saying it may one day be viewed as “akin to asbestos.” Jarman cited NHS-related research and a case highlighted by Hull University Teaching Hospitals NHS Trust: a 15-year-old admitted with chest pain and breathing difficulty who reported cannabis use and vaping about 500 puffs per day and was diagnosed via CT with “air leak syndrome.”
Feb.27 by 2FIRSTS.ai
2Firsts’ Nine Global Turning Points: How 2025 Reshaped the Nicotine Industry
2Firsts’ Nine Global Turning Points: How 2025 Reshaped the Nicotine Industry
In 2025, the global nicotine industry reached a critical turning point. Regulatory realignment, category shifts, capital repositioning and technological intervention unfolded in parallel, loosening old structures while new ones took shape. 2Firsts reviews nine pivotal events that reshaped the industry’s trajectory.
Jan.14
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24